INSULIN BIOSIMILARS MARKET ANALYSIS

Insulin Biosimilars Market, by Biosimilar Type (Rapid-acting Biosimilars, Long-acting Biosimilars, and Premixed Biosimilars), by Disease Indication Type (Type 1 Diabetes and Type 2 Diabetes), and by Geography - Size, Share, Outlook and Opportunity Analysis, 2022-2028

To Be Published : Dec 2024
Code : CMI1750
Formats :
Excel and PDF
Industry : Biotechnology

Market Challenges And Opportunities

However, critical regulatory requirements for approval of insulin biosimilar products besides strong opposition from branded manufactures regarding patent rights, high cost of production, manufacturing complexities, and various safety concerns associated with changes in drug formulations pose as factors hampering growth of the insulin biosimilars market.